PMID: 8604173Jan 17, 1996Paper

Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working Group

JAMA : the Journal of the American Medical Association
D B JerniganR F Breiman

Abstract

Emergence of drug-resistant Streptococcus pneumoniae (DRSP) presents a challenge to the medical and public health communities since the magnitude of the problem is not known, the clinical impact of DRSP infections is not well described, national vaccination rates are low, and antimicrobial drugs are often used excessively and inappropriately. To address the problem of DRSP, a working group by Centers for Disease Control and Prevention was formed in June 1994 consisting of public health practitioners, health care providers, and clinical laboratorians representing state and federal agencies and various professional organizations. Through periodic open meetings, the working group has developed a strategy for surveillance, investigation, prevention, and control of infections due to DRSP. The strategy focuses on (1) implementing an electronic laboratory-based surveillance (ELBS) system for reporting invasive DRSP infections and providing clinically relevant feedback to clinicians, (2) identifying risk factors and outcomes of DRSP infection, (3) increasing pneumococcal vaccination, and (4) promoting judicious antimicrobial drug use. Data received through ELBS will be used to make timely estimates of the community-specific prevalence ...Continue Reading

Citations

Sep 12, 1998·Journal of General Internal Medicine·R GonzalesJ F Steiner
Oct 1, 1996·Emerging Infectious Diseases·M A Winker
Oct 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·S BonhoefferB R Levin
Jun 11, 1998·Emerging Infectious Diseases·D P Fidler
May 31, 2001·Microbiology and Molecular Biology Reviews : MMBR·M J Jedrzejas
May 25, 2002·Emerging Infectious Diseases·John QualeSimona Bratu
Apr 19, 2003·Emerging Infectious Diseases·Linda F McCaigJames M Hughes
Oct 2, 2003·Emerging Infectious Diseases·Jodi Vanden EngRichard E Besser
Jul 27, 2004·Antimicrobial Agents and Chemotherapy·Liana R MerzVictoria J Fraser
Jan 26, 2000·Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie·A A Lindberg
Mar 23, 1999·Indian Journal of Medical Sciences·D D Banker
Aug 1, 1997·Journal of Paediatrics and Child Health·K GrimwoodP B McIntyre
Jan 1, 1997·Annual Review of Public Health·P Lee, D Paxman
Mar 5, 2003·Vaccine·Richard Kent ZimmermanStephen A Wilson
Nov 30, 2000·Current Infectious Disease Reports·R L Wientzen, C Barbey-Morel
Nov 30, 2000·Current Infectious Disease Reports·O Osiyemi, G Dickinson
Feb 21, 2002·Current Infectious Disease Reports·Allan R. Tunkel, W. Michael Scheld
Nov 1, 2001·Diagnostic Microbiology and Infectious Disease·R L LarkJ J Plorde
Dec 24, 1997·Diagnostic Microbiology and Infectious Disease·M A Pfaller, R N Jones
Apr 1, 2005·European Journal of Pediatrics·Gonca Barit, Abdullah Sakarcan
Jul 30, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Julia Y MoritaCynthia G Whitney
Mar 23, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rebecca H SunenshineUNKNOWN Infectious Diseases Society of America Emerging Infections Network
Dec 14, 1999·International Journal of Antimicrobial Agents·H ChardonM Weber
Jan 1, 1997·Scandinavian Journal of Infectious Diseases·B ChristensonB Noreen
Dec 24, 1997·Chest·C S BryanM S Stinson
Jul 3, 2013·The Medical Clinics of North America·Samuel Y Ash, John V L Sheffield
Jan 24, 2012·Vaccine·Carlos Castañeda-OrjuelaFernando De la Hoz-Restrepo
Jul 8, 2000·Pediatric Annals·A C Nyquist
May 27, 2004·Journal of the American Geriatrics Society·Michael A SteinmanRalph Gonzales
Nov 20, 1998·The Journal of Infection·J AliskyN Troitsky
May 1, 1997·Current Problems in Pediatrics·S L Kaplan
Jan 21, 2006·Diagnostic Microbiology and Infectious Disease·Lalitagauri M DeshpandeUNKNOWN SENTRY Antimicrobial Surveillance Program (2001-2004)
Dec 1, 1996·Infectious Disease Clinics of North America·S Segal-MaurerJ J Rahal
Dec 24, 2003·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Visanu Thamlikitkul, Wisit Apisitwittaya
Nov 12, 2016·The American Journal of Emergency Medicine·John P HaranPatricia L Hibberd
Nov 17, 2011·The Journal of Antimicrobial Chemotherapy·Joanna C CrockerChristopher C Butler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.